Glucose degradation products in peritoneal dialysis fluids: How they can be avoided

被引:0
|
作者
Wieslander, A [1 ]
Linden, T [1 ]
Kjellstrand, P [1 ]
机构
[1] Gambro Corp Res, Lund, Sweden
来源
PERITONEAL DIALYSIS INTERNATIONAL | 2001年 / 21卷
关键词
advanced glycation end-products; AGE; biocompatibility; cytotoxicity; glucose degradation products; GDP; in vitro; peritoneal dialysis fluids;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives: A patient on peritoneal dialysis (PD) uses 3 - 7 tons of PD fluid every year. The result is considerable stress on the peritoneal tissue. Aspects of PD fluids that have been considered responsible for bioincompatibility are low pH, high osmolality, high glucose and lactate concentrations, and the presence of glucose degradation products (GDPs). However, the relative importance of each factor in PD fluid has so far not been Investigated. Discovering their relative Importance was the aim of the present study. Methods: Two main methods for investigating biocompatibility were used in this study: cytotoxicity measured as in vitro inhibition of cell growth, and in vitro AGE formation measured as albumin-linked fluorescence. Resuits:The two most Important factors for determining in vitro bioincompatibility of PD fluids were the presence of GDPs, which caused both severe cytotoxicity and strong AGE promotion, and low pH, which induced severe cytotoxicity. Conclusions: The biocompatibility of PD fluids can be monitored through fairly simple in vitro methods such as cell proliferation and AGE formation. Bioincompatibility of PD fluids is caused mainly by the presence of GDPs and low pH. These findings correlate well with known clinical bioincompatibility.
引用
收藏
页码:S119 / S124
页数:6
相关论文
共 50 条
  • [31] Glucose degradation products in peritoneal dialysis fluids may have both local and systemic effects:: a study of residual fluid and mesothelial cells
    Linden, T
    Musi, B
    Järkelid, L
    Forsbäck, G
    Kjellstrand, P
    Deppisch, R
    Wieslander, A
    PERITONEAL DIALYSIS INTERNATIONAL, 2001, 21 (06): : 607 - 610
  • [32] Can biocompatible dialysis fluids improve outcomes in peritoneal dialysis patients?
    Woodrow, G
    PERITONEAL DIALYSIS INTERNATIONAL, 2005, 25 (03): : 230 - 233
  • [33] Neutral pH and low-glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysis
    Schaefer, Betti
    Bartosova, Maria
    Macher-Goeppinger, Stephan
    Sallay, Peter
    Voros, Peter
    Ranchin, Bruno
    Vondrak, Karel
    Ariceta, Gema
    Zaloszyc, Ariane
    Bayazit, Aysun K.
    Querfeld, Uwe
    Cerkauskiene, Rimante
    Testa, Sara
    Taylan, Christina
    VandeWalle, Johan
    Yap, YokChin
    Krmar, Rafael T.
    Buescher, Rainer
    Muhlig, Anne K.
    Drozdz, Dorota
    Caliskan, Salim
    Lasitschka, Felix
    Fathallah-Shaykh, Sahar
    Verrina, Enrico
    Klaus, Gunter
    Arbeiter, Klaus
    Bhayadia, Raj
    Melk, Anette
    Romero, Philipp
    Warady, Bradley A.
    Schaefer, Franz
    Ujszaszi, Akos
    Schmitt, Claus Peter
    KIDNEY INTERNATIONAL, 2018, 94 (02) : 419 - 429
  • [34] The Effect of Far-Infrared Therapy on the Peritoneal Expression of Glucose Degradation Products in Diabetic Patients on Peritoneal Dialysis
    Lin, Chih-Ching
    Niu, Chih-Yuan
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 333 - 333
  • [35] Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model
    Kim, Chan-Duck
    Kwon, Hyeog-Man
    Park, Sun-Hee
    Oh, Eun-Joo
    Kim, Mi-Hyung
    Choi, Soon-Youn
    Choi, Min-Jeong
    Kim, In-San
    Park, Min-Sun
    Kim, Yong-Jin
    Kim, Yong-Lim
    THERAPEUTIC APHERESIS AND DIALYSIS, 2007, 11 (01) : 56 - 64
  • [36] The Effect of Far-Infrared Therapy on the Peritoneal Expression of Glucose Degradation Products in Diabetic Patients on Peritoneal Dialysis
    Chang, Chia-Ning
    Niu, Chih-Yuan
    Tan, Ann Charis
    Chan, Chia-Hao
    Chen, Chun-Fan
    Chen, Tz-Heng
    Li, Szu-Yuan
    Chen, Yung-Tai
    Chen, Fan-Yu
    Li, Wen-Sheng
    Lin, Chih-Ching
    Wei, Guor-Jien
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (07)
  • [37] Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: Role of acidity, buffer choice, glucose concentration, and glucose degradation products
    Mortier, S
    De Vriese, AS
    Van de Voorde, J
    Schaub, TP
    Passlick-Deetjen, J
    Lameire, NH
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (02): : 480 - 489
  • [38] Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products
    Rippe, B
    Simonsen, O
    Heimbürger, O
    Christensson, A
    Haraldsson, B
    Stelin, G
    Weiss, L
    Nielsen, FD
    Bro, S
    Friedberg, M
    Wieslander, A
    KIDNEY INTERNATIONAL, 2001, 59 (01) : 348 - 357
  • [39] Reducing the formation of glucose degradation products in peritoneal dialysis solutions by ultrahigh temperature ohmic heating
    Shapira, Alina
    Shazman, Asher
    Ungar, Yael
    Shimoni, Eyal
    MOLECULAR NUTRITION & FOOD RESEARCH, 2007, 51 (04) : 473 - 478
  • [40] Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells
    Witowski, J
    Korybalska, K
    Ksiazek, K
    Wisniewska-Elnur, J
    Jörres, A
    Lage, C
    Schaub, TP
    Passlick-Deetjen, J
    Breborowicz, A
    Grzegorzewska, A
    Ksiazek, A
    Liberek, T
    Lichodziejewska-Niemierko, M
    Majdan, M
    Rutkowski, B
    Stompór, T
    Sulowicz, W
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (04) : 917 - 924